Skip to main content

Author Guidelines

Please adhere to the following guidelines as closely as possible to facilitate the editorial and production process. If you have any questions, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..
The Oncology Pharmacist (TOP) invites readers to submit articles relevant to in-office dispensing pharmacists, board certified oncology pharmacists, pharmacy directors, and P&T committee members to meet the mission of the journal.

General Information
Manuscripts submitted to TOP must be original and must not have been published previously, either in print or in electronic form. Manuscripts cannot be submitted elsewhere while under consideration by TOP.
Authors are responsible for providing sources cited in the manuscript upon request from the editorial department as part of the standard editorial process.
All authors must sign an appropriate disclosure form and a copyright transfer/authorship form.

Editorial Review
All articles undergo an initial internal review for topic appropriateness and manuscript format. Manuscripts that are not submitted according to the guidelines in this document will be returned to the author.
Authors are notified as soon as possible regarding the initial decision of acceptance or rejection of the article.

Editing
Routine editorial changes are made on all articles to conform to house style, following the AMA Manual of Style, 11th edition.1 The edited manuscript may be sent to the corresponding author for a final review and for any outstanding editorial queries. Time from submission to publication is generally 1 to 3 months, but could be longer, depending on the editing and revision processes.

Manuscript Format
Manuscripts that do not adhere to the format described in this document will be returned to the author.

Title Page
Include a proper title for the article and list the names, titles, and affiliations of all authors. Also list the name, address, telephone number, and e-mail address of the corresponding author.

Text
The entire text must be provided as a double-spaced Word file and all pages numbered consecutively. Cite any graphic elements (tables, figures, algorithms, appendix) consecutively in the text, but place actual tables/figures at the end of the article, after the references. Limit the length of the text to 1000-2000 words (excluding references, tables, and figures).

Tables and Figures
Cite all figures, tables, algorithms, and other graphics in the text, but place the graphic elements at the end of the article, after the references. Type all tables and all figure heads and captions in the Word document.

Figures and other images (excluding tables) must also be provided as individual graphic files, saved at high resolution (300 dpi), as jpg or pdf file. Attach an individual file for each image. Images not saved appropriately will delay the editing process significantly. For help with images, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..

References
Cite references consecutively in the text using superscript Arabic numerals. Do not use automatic numbering or footnote/endnote features. Use the most up-to-date, post-2000 references, citing primary sources only. Try to limit the number of references to 10. Place the complete reference list at the end of the text under the heading References.

Use reference format according to the AMA Manual of Style, 11th ed.1

Examples:

  1. Peters JL, Sutton AJ, Jones DR, et al. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295:676-680.
  2. McGrath JJ, Murray RM. Risk factors for schizophrenia: from conception to birth. In: Hirsch SR, Weinberger DR, eds. Schizophrenia. Oxford, England: Blackwell Press; 2003.
  3. Waters R, Pettypiece S. Drug sales in the US grow at slower pace as generic use surges. March 12, 2008. www.Bloomberg.com/apps/news?pid=newsarchive&sid=aLfUw7_sYMRY. Accessed March 13, 2008.

Permissions
Authors must secure written permission to reuse or adapt any graphic elements (table, figure) from a previously published (online or in print) article or from any other source. Provide the letter of permission when submitting the manuscript, or indicate that permission will be provided, and cite the original source with the graphic element in the manuscript. Authors are responsible for acknowledging all information that has been published previously.

Authorship/Copyright
Authors listed on the manuscript should only include those who have made a direct contribution to the content of the article, in accordance with the authorship criteria provide by the International Committee of Medical Journal Editors (ICMJE).2
Provide authors’ highest academic degree and professional affiliations. Also provide the name, address, telephone number, and e-mail of the corresponding author. The corresponding author is responsible for securing signatures for all forms from all authors and for getting final approval from all authors for the version of the article being published.
All authors are required to sign an Authorship/Copyright Transfer Form, assigning all copyrights for the manuscript to Amplity Health, publisher of TOP.

Disclosure Statements
All authors must disclose any relationship that could be viewed as a potential conflict of interest, based on ICMJE guidelines,2 including any financial interests, direct or indirect, and any affiliations or involvement (competitive or amiable) with organizations that have a financial interest in the subject matter or materials discussed in the manuscript. Each author must sign the Financial Disclosure Form in accordance with the ICMJE guidelines.2
TOP discloses all information regarding employment, consultancies, stock ownership, honoraria, grants, or other financial sources with potential conflict of interest in relation to a manuscript, or if authors discuss any products or services with such commercial interest. Any information regarding funding, grants, or other financial compensation must be listed on the title page of the manuscript. All published articles will include disclosure statements listing any relationships with real or potential conflict of interest for all authors and for the manuscript/research.

How to Submit
Complete articles (containing title, authors, figures, tables, references) should be submitted via e-mail to This email address is being protected from spambots. You need JavaScript enabled to view it.. Per journal policy, authors will be required to complete and sign copyright release forms. Any questions regarding these guidelines should be sent to This email address is being protected from spambots. You need JavaScript enabled to view it..

Reprints
Reprints may be ordered for a nominal fee by contacting This email address is being protected from spambots. You need JavaScript enabled to view it..

References

  1. American Medical Association. AMA Manual of Style. A Guide for Authors and Editors. 11th ed. Oxford University Press; 2020.
  2. International Committee of Medical Journal Editors. Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. Updated May 2022. www.icmje.org/icmje-recommendations.pdf. Accessed May 12, 2023.

About TOP
Mission Statement
The Oncology Pharmacist® features articles written by and for oncology pharmacists and specifically addresses the issues pharmacists and their colleagues face every day in clinical practice in a quick, easy-to-read format. In addition to news on the latest research findings and results of large clinical trials, issues include interviews with thought leaders, articles of interest to pharmacy students and residents, and articles on practice management.